Metabolic tumour volume as prognostic factor for early response to treatment in advanced stage Hodgkin lymphoma

被引：0
|
作者：
Kreissl, S. [1 ,2 ]
Mueller, H. [2 ]
Voltin, C. -A. [3 ]
Baues, C. [2 ,4 ]
Klaeser, B. [5 ]
Moccia, A. [6 ,7 ]
Borchmann, P. [1 ,2 ]
Engert, A. [1 ,2 ]
Kuhnert, G. [3 ]
Drzezga, A. [3 ]
Dietlein, M. [2 ,3 ]
Kobe, C. [2 ,3 ]
Mettler, J. [2 ,3 ]
机构：
[1] Uniklin Koln, Innere Med 1, Cologne, Germany
[2] German Hodgkin Study Grp GHSG, Cologne, Germany
[3] Uniklin Koln, Abt Nukl Med, Cologne, Germany
[4] Uniklin Koln, Abt Strahlentherapie, Cologne, Germany
[5] Bern Univ Hosp, Inselspital, Bern, Switzerland
[6] Oncol Inst Southern Switzerland, Med Onkol, Bellinzona, Switzerland
[7] Swiss Grp Clin Canc Res, Bern, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P432
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [41] Treatment options for early-stage Hodgkin's lymphoma
    Venkatesan, Priya
    LANCET ONCOLOGY, 2017, 18 (06): : E304 - E304
  • [42] Treatment of early-stage supradiaphragmatic Hodgkin's lymphoma
    Ferme, C.
    ONCOLOGIE, 2008, 10 (05) : 303 - 306
  • [43] Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
    Glimelius, I
    Molin, D
    Amini, RM
    Gustavsson, A
    Glimelius, B
    Enblad, G
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (05) : 327 - 333
  • [44] The Complementary Prognostic Role of Baseline and Interim PET in Predicting Treatment Outcome in Advanced-Stage Hodgkin Lymphoma
    Cimino, Giuseppe
    Zaucha, Jan Maciej
    Cirillo, S.
    Saviolo, C.
    Hutchings, Martin
    El-Galaly, T. C.
    Borra, Anna
    Rago, Angela
    Gallamini, Andrea
    BLOOD, 2014, 124 (21)
  • [45] Metabolic Tumor Volume Measurement In Early Hodgkin Lymphoma. Preliminary Results
    Cortes Romera, M.
    Palomar-Munoz, A.
    Domingo-Domenech, E.
    Reynes-Llompart, G.
    Vercher-Conejero, J.
    Notta, P.
    Sureda-Balari, A.
    Mestres-Marti, J.
    Gamez-Cenzano, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S555 - S556
  • [46] Treatment of early and intermediate stage Hodgkin's lymphoma in the German Hodgkin's Lymphoma Study Group
    Wiedenmann, S
    Schiller, P
    Paulus, U
    Wolf, J
    ANNALS OF ONCOLOGY, 2002, 13 : 84 - 85
  • [47] New strategies for the treatment of advanced-stage Hodgkin's lymphoma
    Diehl, Volker
    Engert, Andreas
    Re, Daniel
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (05) : 897 - +
  • [48] Treatment results in advanced stage Hodgkin's lymphoma: A retrospective study
    Jain, H.
    Sengar, M.
    Nair, R.
    Menon, H.
    Laskar, S.
    Shet, T.
    Gujral, S.
    Sridhar, E.
    JOURNAL OF POSTGRADUATE MEDICINE, 2015, 61 (02) : 88 - 91
  • [49] Metabolic tumour volume in Hodgkin lymphoma - a comparison between manual and AI-based analysis
    Sadik, M.
    Barrington, S. F.
    Ulen, J.
    Enqvist, O.
    Tragardh, E.
    Saboury, B.
    Nielsen, A. Lerberg
    Jakobsen, A. Loft
    Gongora, J. Loaiza
    Lopez-Urdaneta, J.
    Kumar, R.
    Edenbrandt, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S557 - S558
  • [50] The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma
    Koca, Oguzhan
    Ozyurt, Berk
    Umar, Aysenur
    Ozmen, Deniz
    Elverdi, Tugrul
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Baslar, Zafer
    Eskazan, Ahmet Emre
    ANNALS OF HEMATOLOGY, 2025, : 1765 - 1775
12345